Experiences of the molecular diagnosis of fragile X syndrome in Ecuador

Fragile X syndrome (FXS) is the most common cause of hereditary intellectual disability and the second most common cause of intellectual disability of genetic etiology. This complex neurodevelopmental disorder is caused by an alteration in the CGG trinucleotide expansion in fragile X mental retardat...

Full description

Bibliographic Details
Main Authors: Lopez Caceres, Andrea Del pilar, Pozo Palacios, Juan Carlos, Llamos Paneque, Arianne, Rivas, Christian, Onofre, Emily, Villareal, Jennifer
Format: ARTÍCULO
Language:es_ES
Published: 2022
Subjects:
Online Access:http://dspace.ucuenca.edu.ec/handle/123456789/37996
https://www.scopus.com/record/display.uri?eid=2-s2.0-85121809131&origin=resultslist&sort=plf-f&src=s&st1=Experiences+of+the+Molecular+Diagnosis+of+Fragile+X+Syndrome+in+Ecuador&sid=9c81de9cf244c46ca8aa3c7d76c0e1d4&sot=b&sdt=b&sl=86&s=TITLE-ABS-KEY%28Experiences+of+the+Molecular+Diagnosis+of+Fragile+X+Syndrome+in+Ecuador%29&relpos=0&citeCnt=0&searchTerm=
_version_ 1793400622266974208
author Lopez Caceres, Andrea Del pilar
Pozo Palacios, Juan Carlos
Llamos Paneque, Arianne
Rivas, Christian
Onofre, Emily
Villareal, Jennifer
author_facet Lopez Caceres, Andrea Del pilar
Pozo Palacios, Juan Carlos
Llamos Paneque, Arianne
Rivas, Christian
Onofre, Emily
Villareal, Jennifer
author_sort Lopez Caceres, Andrea Del pilar
collection DSpace
description Fragile X syndrome (FXS) is the most common cause of hereditary intellectual disability and the second most common cause of intellectual disability of genetic etiology. This complex neurodevelopmental disorder is caused by an alteration in the CGG trinucleotide expansion in fragile X mental retardation gene 1 (FMR1) leading to gene silencing and the subsequent loss of its product: fragile X mental retardation protein 1 (FMRP). Molecular diagnosis is based on polymerase chain reaction (PCR) screening followed by Southern blotting (SB) or Triplet primer-PCR (TP-PCR) to determine the number of CGG repeats in the FMR1 gene. We performed, for the first time, screening in 247 Ecuadorian male individuals with clinical criteria to discard FXS. Analysis was carried out by the Genetics Service of the Hospital de Especialidades No. 1 de las Fuerzas Armadas (HE-1), Ecuador. The analysis was performed using endpoint PCR for CGG fragment expansion analysis of the FMR1 gene. Twenty-two affected males were identified as potentially carrying the full mutation in FMR1 and thus diagnosed with FXS that is 8.1% of the sample studied. The average age at diagnosis of the positive cases was 13 years of age, with most cases from the geographical area of Pichincha (63.63%). We confirmed the familial nature of the disease in four cases. The range of CGG variation in the population was 12–43 and followed a modal distribution of 27 repeats. Our results were similar to those reported in the literature; however, since it was not possible to differentiate between premutation and mutation cases, we can only establish a molecular screening approach to identify an expanded CGG repeat, which makes it necessary to generate national strategies to optimize molecular tests and establish proper protocols for the diagnosis, management, and follow-up of patients, families, and communities at risk of presenting FXS. Copyright © 2021 Pozo-Palacios, Llamos-Paneque, Rivas, Onofre, López-Cáceres and Villareal.
format ARTÍCULO
id oai:dspace.ucuenca.edu.ec:123456789-37996
institution Universidad de Cuenca
language es_ES
publishDate 2022
record_format dspace
spelling oai:dspace.ucuenca.edu.ec:123456789-379962024-02-01T19:41:37Z Experiences of the molecular diagnosis of fragile X syndrome in Ecuador Lopez Caceres, Andrea Del pilar Pozo Palacios, Juan Carlos Llamos Paneque, Arianne Rivas, Christian Onofre, Emily Villareal, Jennifer Repetitions Dynamic mutation diseases FMR1 Fragile X syndrome Intellectual disabilities Fragile X syndrome (FXS) is the most common cause of hereditary intellectual disability and the second most common cause of intellectual disability of genetic etiology. This complex neurodevelopmental disorder is caused by an alteration in the CGG trinucleotide expansion in fragile X mental retardation gene 1 (FMR1) leading to gene silencing and the subsequent loss of its product: fragile X mental retardation protein 1 (FMRP). Molecular diagnosis is based on polymerase chain reaction (PCR) screening followed by Southern blotting (SB) or Triplet primer-PCR (TP-PCR) to determine the number of CGG repeats in the FMR1 gene. We performed, for the first time, screening in 247 Ecuadorian male individuals with clinical criteria to discard FXS. Analysis was carried out by the Genetics Service of the Hospital de Especialidades No. 1 de las Fuerzas Armadas (HE-1), Ecuador. The analysis was performed using endpoint PCR for CGG fragment expansion analysis of the FMR1 gene. Twenty-two affected males were identified as potentially carrying the full mutation in FMR1 and thus diagnosed with FXS that is 8.1% of the sample studied. The average age at diagnosis of the positive cases was 13 years of age, with most cases from the geographical area of Pichincha (63.63%). We confirmed the familial nature of the disease in four cases. The range of CGG variation in the population was 12–43 and followed a modal distribution of 27 repeats. Our results were similar to those reported in the literature; however, since it was not possible to differentiate between premutation and mutation cases, we can only establish a molecular screening approach to identify an expanded CGG repeat, which makes it necessary to generate national strategies to optimize molecular tests and establish proper protocols for the diagnosis, management, and follow-up of patients, families, and communities at risk of presenting FXS. Copyright © 2021 Pozo-Palacios, Llamos-Paneque, Rivas, Onofre, López-Cáceres and Villareal. 2022-02-08T16:45:25Z 2022-02-08T16:45:25Z 2021 ARTÍCULO 1664-0640 http://dspace.ucuenca.edu.ec/handle/123456789/37996 https://www.scopus.com/record/display.uri?eid=2-s2.0-85121809131&origin=resultslist&sort=plf-f&src=s&st1=Experiences+of+the+Molecular+Diagnosis+of+Fragile+X+Syndrome+in+Ecuador&sid=9c81de9cf244c46ca8aa3c7d76c0e1d4&sot=b&sdt=b&sl=86&s=TITLE-ABS-KEY%28Experiences+of+the+Molecular+Diagnosis+of+Fragile+X+Syndrome+in+Ecuador%29&relpos=0&citeCnt=0&searchTerm= 10.3389/fpsyt.2021.716311 es_ES application/pdf Frontiers in Psychiatry
spellingShingle Repetitions
Dynamic mutation diseases
FMR1
Fragile X syndrome
Intellectual disabilities
Lopez Caceres, Andrea Del pilar
Pozo Palacios, Juan Carlos
Llamos Paneque, Arianne
Rivas, Christian
Onofre, Emily
Villareal, Jennifer
Experiences of the molecular diagnosis of fragile X syndrome in Ecuador
title Experiences of the molecular diagnosis of fragile X syndrome in Ecuador
title_full Experiences of the molecular diagnosis of fragile X syndrome in Ecuador
title_fullStr Experiences of the molecular diagnosis of fragile X syndrome in Ecuador
title_full_unstemmed Experiences of the molecular diagnosis of fragile X syndrome in Ecuador
title_short Experiences of the molecular diagnosis of fragile X syndrome in Ecuador
title_sort experiences of the molecular diagnosis of fragile x syndrome in ecuador
topic Repetitions
Dynamic mutation diseases
FMR1
Fragile X syndrome
Intellectual disabilities
url http://dspace.ucuenca.edu.ec/handle/123456789/37996
https://www.scopus.com/record/display.uri?eid=2-s2.0-85121809131&origin=resultslist&sort=plf-f&src=s&st1=Experiences+of+the+Molecular+Diagnosis+of+Fragile+X+Syndrome+in+Ecuador&sid=9c81de9cf244c46ca8aa3c7d76c0e1d4&sot=b&sdt=b&sl=86&s=TITLE-ABS-KEY%28Experiences+of+the+Molecular+Diagnosis+of+Fragile+X+Syndrome+in+Ecuador%29&relpos=0&citeCnt=0&searchTerm=
work_keys_str_mv AT lopezcaceresandreadelpilar experiencesofthemoleculardiagnosisoffragilexsyndromeinecuador
AT pozopalaciosjuancarlos experiencesofthemoleculardiagnosisoffragilexsyndromeinecuador
AT llamospanequearianne experiencesofthemoleculardiagnosisoffragilexsyndromeinecuador
AT rivaschristian experiencesofthemoleculardiagnosisoffragilexsyndromeinecuador
AT onofreemily experiencesofthemoleculardiagnosisoffragilexsyndromeinecuador
AT villarealjennifer experiencesofthemoleculardiagnosisoffragilexsyndromeinecuador